Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The announcement by Amazon, Berkshire Hathaway and JPMorgan Chase has already disrupted the stock market. Here’s why.
The move may reverse an exclusive deal signed between rival hepatitis C drugmaker AbbVie Inc. and Express Scripts in 2014.
In late October, the FDA reported that Viekira Pak and Technivie were causing liver injury in certain patients.
New HCV treatment boasts over 90 percent cure rates, costs $84,000 for in the United States, and is being distributed at 1 percent of the cost...
Groundbreaking new hep C treatments have been approved for people with genotype 1 of the virus. Insurers are striking coverage deals with the...
Anthem is the largest insurance provider for businesses in the United States.
CVS is taking the opposite stance of its competitor Express Scripts.
The pharmacy benefit manager Express Scripts has will only reimburse for AbbVie?s hepatitis C regimen for people with genotype 1 of the virus.
The PBM will consider making the switch if AbbVie’s new ’3D’ drug turns out to be clinically equivalent to Gilead’s treatment.
Express Scripts is urging its insurers to try pushing Gilead out of the hepatitis C treatment market as early as this fall.
The pharmacy benefits company may pit Gilead Sciences against AbbVie and other drugmakers by threatening to block new drugs from reimbursement...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.